Regional webinar: Cervical Cancer Elimination in the Asia Pacific – Time for Action
IPVS regional webinar in collaboration with the Asia Pacific HPV Coalition: Cervical Cancer Elimination in the Asia Pacific – Time for Action Friday, 25 August 2023 08:30-10:00 CEST (Geneva)/ 14:30-16:00 SGT (Singapore) Topic: Join us for a free webinar held jointly with the Asia Pacific HPV Coalition where we delve into the intricacies of implementing […]
IPVS webinar – Self-sampling for Human Papillomavirus Testing
IPVS webinar – Self-sampling for Human Papillomavirus Testing Monday, 23 January 2023 17:00 – 18:00 CET (Geneva) / 11:00 – 12:00 EST (New York) Topic: Join this first live educational webinar of the year for discussions on self-sampling for HPV testing. The following topics will be addressed: Diagnostic accuracy of high-risk human papillomavirus (hrHPV) assays […]
IPVS Regional Webinar 2021: Cervical Cancer Elimination in Asia Pacific
Register today for the IPVS regional webinar in collaboration with the APAC HPV Coalition: Session III: Cervical cancer vaccination & screening in the Asia pacific during the pandemic: Where do we go from here? 15 May 2021 08:00-9:00 CET (Geneva)/ 14:00-15:00 SST (Singapore) Topic: What are the main challenges in cervical cancer screening and prevention […]
IPVS webinar – HPV-Related Head and Neck Cancers: Epidemiology, novel therapeutics and impact
IPVS webinar – HPV-Related Head and Neck Cancers: Epidemiology, novel therapeutics and impact Thursday, July 27, 2023 16:00 – 17:00 CEST (Geneva) / 10:00 – 11:00 EDT (New York) Topic: Join us on July 27th to commemorate World Head and Neck Cancer Day with an important and free webinar. We will delve into critical aspects […]
IPVS webinar – WHO recommendations on HPV vaccine schedule optimization
IPVS webinar – Update on WHO recommendations on HPV vaccine schedule optimization and implications for the field Wednesday, 22 February 2023 15:00 – 16:00 CET (Geneva) / 9:00 – 10:00 EST (New York) Topic: Join this live and free webinar for discussions on global policy on HPV vaccination and implementation considerations. Get the latest updates […]
IPVS/IANS webinar – Anal HPV and host interactions
Joint IANS/IPVS webinar: Anal HPV and host interactions Wednesday, 6 September 2023 16:00 – 17:00 CEST (Geneva) / 10:00 – 11:00 EDT (New York) Join us for a free webinar on anal HPV and host interactions in Anal Intraepithelial Neoplasia (AIN) and Cancer. In this live session, we will delve into cutting-edge research and knowledge […]
IPVS webinar – Highlights of the 2021 NCI Workshop on Antiviral Drug Development for Human Papillomaviruses
IPVS webinar – Highlights of the 2021 NCI Workshop on Antiviral Drug Development for Human Papillomaviruses Wednesday, 23rd March 2022 12:00-13:00 EDT (New York) / 17:00-18:00 CET (Geneva) Topic: Have you missed the 2021 NCI Workshop on Antiviral Drug Development for Human Papillomaviruses or would you like to learn more about HPV antiviral drugs? Join […]
IPVS webinar – Your patient is HPV+: what is next?
IPVS webinar – Your patient is HPV+: what is next? Tuesday, 13th July 2021 8:00 EDT (New York) / 14:00 CEST (Geneva) / 20:00 SST (Singapore) Topic: Given the strong evidence that HPV-based screening is more effective than cytology or naked visual inspection after application of acetic acid, more and more countries have switched or […]
IPVS webinar: Everything you need to know about HPV and pregnancy
IPVS webinar: Everything you need to know about HPV and pregnancy Thursday, 28th April 2022 12:00-13:30 EDT (New York) / 18:00-19:30 CEST (Geneva) Topic: Join our upcoming webinar to learn everything you need to know about HPV and pregnancy. HPV lesion treatment is known to be associated with obstetrical complications and now HPV infection in […]
IPVS webinar: Testing positive for HPV in cervical screening
IPVS webinar Testing positive for HPV in cervical screening: psychosocial and communication issues for patients and providers Friday, 10th June 2022 9:00-10:00 EDT (New York) / 15:00-16:00 CEST (Geneva) Topic: HPV screening is changing the scope of screening from abnormal cells to a virus that is sexually transmitted. Reluctance from health professionals having to counsel […]
